Europe Quetiapine Intermediate Chemicals Market Size & Outlook

The quetiapine intermediate chemicals market in Europe is expected to reach a projected revenue of US$ 14,635.0 million by 2030. A compound annual growth rate of 4.8% is expected of Europe quetiapine intermediate chemicals market from 2025 to 2030.
Revenue, 2024 (US$M)
$11,055.1
Forecast, 2030 (US$M)
$14,635.0
CAGR, 2025 - 2030
4.8%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe quetiapine intermediate chemicals market, 2018-2030 (US$M)

Europe quetiapine intermediate chemicals market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe quetiapine intermediate chemicals market highlights

  • The Europe quetiapine intermediate chemicals market generated a revenue of USD 11,055.1 million in 2024.
  • The market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
  • In terms of segment, pharmaceuticals was the largest revenue generating end use in 2024.
  • Pharmaceuticals is the most lucrative end use segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 11,055.1 million
Market revenue in 2030USD 14,635.0 million
Growth rate4.8% (CAGR from 2025 to 2030)
Largest segmentPharmaceuticals
Fastest growing segmentPharmaceuticals
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPharmaceuticals


Other key industry trends

  • In terms of revenue, Europe region accounted for 22.4% of the global quetiapine intermediate chemicals market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 34,061.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Quetiapine Intermediate Chemicals Market Companies

Name Profile # Employees HQ Website
Allchem Lifescience View profile 101-250 Vadodara, Gujarat, India, Asia https://www.allchemlifescience.com
A.R. Life Sciences View profile 101-250 Hyderabad, Andhra Pradesh, India, Asia https://www.arlifesciences.com
AMI Organics View profile 251-500 Sachin, Gujarat, India, Asia http://amiorganics.com
Iol Chemicals & Pharmaceutical View profile 1001-5000 Ludhiana, Punjab, India, Asia https://www.iolcp.com/
Luye Pharma Group Ltd View profile 5270 Hongqiao Road 1438, 22/F, Gubei International Fortune Center II, Changning District, Shanghai, China, People's Republic of, 264003 https://www.luye.cn
Aarti Pharmalabs Limited View profile - https://www.aartipharmalabs.com/
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Europe quetiapine intermediate chemicals market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to quetiapine intermediate chemicals market will help companies and investors design strategic landscapes.


Pharmaceuticals was the largest segment with a revenue share of 89.54% in 2024. Horizon Databook has segmented the Europe quetiapine intermediate chemicals market based on pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.


Europe's aging population and increasing awareness of mental health disorders are driving a steady demand for quetiapine, thus increasing the need for its intermediate chemicals. 

The growing focus on generic drug production within the European Union, aimed at cost containment in healthcare, further boosts this demand. 

Ongoing pharmaceutical research and development, focusing on improved formulations and personalized medicine, also contributes to the rising demand for these chemical precursors.

Reasons to subscribe to Europe quetiapine intermediate chemicals market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe quetiapine intermediate chemicals market databook

  • Our clientele includes a mix of quetiapine intermediate chemicals market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe quetiapine intermediate chemicals market , including forecasts for subscribers. This continent databook contains high-level insights into Europe quetiapine intermediate chemicals market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe quetiapine intermediate chemicals market size, by country, 2018-2030 (US$M)

Europe Quetiapine Intermediate Chemicals Market Outlook Share, 2024 & 2030 (US$M)

Europe quetiapine intermediate chemicals market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online